Quantamental Technologies’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Quantamental Technologies’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,000	Closed	-$75K	–	1432
2019 Q3	$75K	Buy	+1,000	New	+$81.2K	0.02%	839
2019 Q2	–	Sell	-800	Closed	-$86K	–	1882
2019 Q1	$86K	Sell	800 -500	-38%	-$49.8K	0.04%	658
2018 Q4	$110K	Buy	+1,300	New	+$125K	0.07%	519

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Quantamental Technologies's TARO Position: Q4 2019 in Review

Quantamental Technologies sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2019, closing a stake of 1,000 shares — an estimated $75K sold.

Quantamental Technologies first reported a position in TARO in Q4 2018 and held it in 3 quarters. The position peaked at $110K in Q4 2018. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2019.

Quantamental Technologies reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2019 after selling out during the quarter.
Quantamental Technologies sold 1,000 Taro Pharmaceutical Industries Ltd. shares in Q4 2019, an estimated $75K.
Quantamental Technologies first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2018 and held it in 3 quarters.
Quantamental Technologies's Taro Pharmaceutical Industries Ltd. position peaked at $110K in Q4 2018.
94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.